Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 9, 2025 • 4:00 AM ET

Date/Time Source News Release
07/01/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System
06/27/2025 09:01 AM EDT GlobeNewswire ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement
06/26/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys
06/25/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology
06/12/2025 08:25 AM EDT GlobeNewswire ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
06/09/2025 09:00 AM EDT GlobeNewswire ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering
06/03/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio
05/21/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update
05/02/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
04/28/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System
Page